The research demonstrates that women are more likely to experience adverse events and less likely to benefit from certain treatments, emphasizing the urgent need for healthcare providers to adopt a sex-informed approach in prescribing practices. Future research should prioritize sex differences from the outset to enhance understanding and improve clinical outcomes for women with chronic kidney disease and cardiovascular conditions.
Keyphrases
- healthcare
- chronic kidney disease
- polycystic ovary syndrome
- primary care
- pregnancy outcomes
- public health
- end stage renal disease
- cervical cancer screening
- current status
- type diabetes
- insulin resistance
- pregnant women
- adipose tissue
- skeletal muscle
- risk assessment
- social media
- metabolic syndrome
- human health
- electronic health record